Daewon Pharm (003220) - Total Liabilities

Latest as of December 2025: ₩339.07 Billion KRW ≈ $229.78 Million USD

Based on the latest financial reports, Daewon Pharm (003220) has total liabilities worth ₩339.07 Billion KRW (≈ $229.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Daewon Pharm to track the company's year-over-year net asset growth rate.

Daewon Pharm - Total Liabilities Trend (2011–2025)

This chart illustrates how Daewon Pharm's total liabilities have evolved over time, based on quarterly financial data. See 003220 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Daewon Pharm Competitors by Total Liabilities

The table below lists competitors of Daewon Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Top Union Electronics TWO:6266	Taiwan	NT$1.32 Billion
The Joint Corp NASDAQ:JYNT	USA	$42.43 Million
AMREP Corporation NYSE:AXR	USA	$4.57 Million
White Pearl Acquisition Corp. NYSE:WPAC	USA	$115.82 Million
King Chou Marine Technology Co Ltd TWO:4417	Taiwan	NT$1.65 Billion
Endeavour Mining Corp LSE:EDV	UK	GBX2.13 Billion
Go Hub Capital Berhad KLSE:0311	Malaysia	RM26.11 Million
Southern Hydropower JSC VN:SHP	Vietnam	₫53.29 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Daewon Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003220 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Daewon Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Daewon Pharm (2011–2025)

The table below shows the annual total liabilities of Daewon Pharm from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩339.07 Billion ≈ $229.78 Million	+13.47%
2024-12-31	₩298.81 Billion ≈ $202.50 Million	+22.60%
2023-12-31	₩243.73 Billion ≈ $165.17 Million	+19.02%
2022-12-31	₩204.78 Billion ≈ $138.78 Million	-3.03%
2021-12-31	₩211.18 Billion ≈ $143.11 Million	+72.47%
2020-12-31	₩122.44 Billion ≈ $82.98 Million	-0.71%
2019-12-31	₩123.32 Billion ≈ $83.57 Million	+33.69%
2018-12-31	₩92.24 Billion ≈ $62.51 Million	+56.15%
2017-12-31	₩59.07 Billion ≈ $40.03 Million	+12.16%
2016-12-31	₩52.67 Billion ≈ $35.69 Million	+14.28%
2015-12-31	₩46.09 Billion ≈ $31.23 Million	-0.04%
2014-12-31	₩46.11 Billion ≈ $31.25 Million	+24.99%
2013-12-31	₩36.89 Billion ≈ $25.00 Million	+7.86%
2012-12-31	₩34.20 Billion ≈ $23.18 Million	-6.23%
2011-12-31	₩36.47 Billion ≈ $24.72 Million	--

About Daewon Pharm

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$118.53 Million

₩174.90 Billion KRW

Market Cap Rank

#18583 Global

#846 in Korea

Share Price

₩8160.00

Change (1 day)

+4.75%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34